| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 10/22/2003 | EP1354062A2 Target activated nucleic acid biosensor and methods of using same |
| 10/22/2003 | EP1354061A2 Novel prkag3 alleles and use of the same as genetic markers for reproductive and meat quality traits |
| 10/22/2003 | EP1354060A2 5t4 rna in plasma and serum as a marker for neoplastic disease |
| 10/22/2003 | EP1354059A1 Method for detecting whether an organism is homozygous or heterozygous using labelled primers and rflp |
| 10/22/2003 | EP1354055A1 Neocentromere-based mini-chromosomes or artificial chromosomes |
| 10/22/2003 | EP1354048A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 10/22/2003 | EP1354047A2 Methods for screening compounds that modulate lipid metabolism |
| 10/22/2003 | EP1354046A2 A member of the lysyl oxidase gene family |
| 10/22/2003 | EP1354044A1 Nurr1 transcription factor i-box mutants having monomeric transcriptional activation activity |
| 10/22/2003 | EP1354043A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 10/22/2003 | EP1354042A2 Proteins and nucleic acids encoding same |
| 10/22/2003 | EP1354039A2 Atp-binding cassette transporter-like molecules and uses thereof |
| 10/22/2003 | EP1354038A2 Double-stranded rna-mediated gene suppression |
| 10/22/2003 | EP1354031A2 Nucleotide incorporating enzymes |
| 10/22/2003 | EP1353954A2 Anticoagulants and their uses |
| 10/22/2003 | EP1353952A2 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy |
| 10/22/2003 | EP1353949A2 Compositions and methods relating to ovary specific genes and proteins |
| 10/22/2003 | EP1353947A2 Gene expression profiling of primary breast carcinomas using arrays of candidate genes |
| 10/22/2003 | EP1353946A2 Mechanism of conditional regulation of the hypoxia-inducible factor-1 by the von hippel-lindau tumor suppressor protein |
| 10/22/2003 | EP1353945A2 Polymorphic kinase anchor proteins and nucleic acids encoding the same |
| 10/22/2003 | EP1353937A2 Specific human antibodies for selective cancer therapy |
| 10/22/2003 | EP1353936A2 Primers and methods for the detection and discrimination of nucleic acids |
| 10/22/2003 | EP1353935A2 Selection of catalytic nucleic acids targeted to infectious agents |
| 10/22/2003 | EP1353688A2 Method and compositions for immunization with the pseudomonas v antigen |
| 10/22/2003 | EP1353687A2 Methods for obtaining inhibitors of tirc7 ligand binding and uses thereof |
| 10/22/2003 | EP1353666A2 Myeloperoxidase, a risk indicator for cardiovascular disease |
| 10/22/2003 | EP1177209B1 Compositions of solvents and high concentrations of nucleic acid analogs |
| 10/22/2003 | EP0986572B1 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof |
| 10/22/2003 | EP0927270B1 Lyophilization of cultured human cells to preserve rna and dna |
| 10/22/2003 | EP0925373B1 Process for detecting nucleic acids by mass determination |
| 10/22/2003 | EP0852620B1 Human jtv1 gene overlaps pms2 gene |
| 10/22/2003 | EP0851927B1 Compounds for immunotherapy and diagnosis of tuberculosis |
| 10/22/2003 | EP0815221B1 A novel growth factor and a genetic sequence encoding same |
| 10/22/2003 | CN2581996Y Biochip |
| 10/22/2003 | CN2581456Y Gene diagnosis sampling box core plate |
| 10/22/2003 | CN1451051A Measuring viral reverse transcriptase activity |
| 10/22/2003 | CN1451050A Method for controlling the microbiological guality of an aqueous medium and kit therefor |
| 10/22/2003 | CN1451049A A nucleic acid-based method for tree phenotype prediction |
| 10/22/2003 | CN1451047A Corynebacterium glutamicum genes encoding stress resistance and tolerance proteins |
| 10/22/2003 | CN1451042A Method of monitoring HIV drug resistance |
| 10/22/2003 | CN1450910A Mutant simplex virus for treating hyperproliferative cell growth |
| 10/22/2003 | CN1450907A Beta glycan as an inhibin receptor and uses thereof |
| 10/22/2003 | CN1450173A SARS related coronal virus total genom chip and use thereof |
| 10/22/2003 | CN1450172A Method for detecting SARS virus and kit thereof |
| 10/22/2003 | CN1450171A Detection type gene chip for detecting various infectious desease and use thereof |
| 10/22/2003 | CN1450170A Method for detecting telomerase activity |
| 10/22/2003 | CN1450164A Novel coronal virus strain and medicinal use thereof |
| 10/22/2003 | CN1125342C Highly specific surfaces for biological reactions, method of preparation and utilization |
| 10/22/2003 | CN1125341C Chemical timer for visual test strip |
| 10/22/2003 | CN1125185C Method for quickly detecting CpG cytosine methylation |
| 10/22/2003 | CN1125184C Low density biochip and its making process |
| 10/22/2003 | CN1125172C Equipment kit and method for microbiological diagnosis |
| 10/22/2003 | CN1125082C Human chemokine beta-8 chemokine beta-1 and macrophage inflammatory protein-4 |
| 10/22/2003 | CA2424577A1 Use of huntingtin and related compounds for modulating cell survival |
| 10/21/2003 | US6635752 Diagnosis of Aids |
| 10/21/2003 | US6635748 Protein for use as antitumor agent; for use as antimetastsis agent |
| 10/21/2003 | US6635744 Substantially pure fibroblast growth factor homologous factor-4 polypeptide having specified amino acid sequence; diagnosis and treatment of neurodegenerative and neoplastic disorders |
| 10/21/2003 | US6635493 Apparatus for use in sequence determination, immunoassays and receptor/ligand assays |
| 10/21/2003 | US6635489 Materials for enhancing staining of biopolymers in matrices |
| 10/21/2003 | US6635483 Antisense polynucleotide targeted to a nucleic acid encoding the gene, thereby suppressing its expression; cDNA encapsulated in liposome; use as antitumor, anticarcinogenic or antiapoptotic; Alzheimer's disease |
| 10/21/2003 | US6635479 Hypothalamus-specific polypeptides |
| 10/21/2003 | US6635477 Comprising a open reading frame; use in diagnosis, treatment and prevention |
| 10/21/2003 | US6635473 Isolated nucleic acid encoding a fibrinogen-binding protein; useful in prevention, diagnosis and treatment of infections; can be administered to wounds or for coating prosthetics to inhibit binding of the bacteria |
| 10/21/2003 | US6635470 Fiber array and methods for using and making same |
| 10/21/2003 | US6635469 Dissociating analyte from endogenous sample and reacting it with a exogenous reagent to enable detection; improves assay speed and sensitivity |
| 10/21/2003 | US6635463 Particularly RNA; polypeptide comprising SEQ ID NO:280; |
| 10/21/2003 | US6635461 Encoded by isolated nucleic acid; has glycosyltransferase activity; given amino acid sequence; useful as diagnostic and therapeutic agent for cancer and thymus-related disorders |
| 10/21/2003 | US6635452 Releasable nonvolatile mass label molecules |
| 10/21/2003 | US6635449 Exonuclease-mediated nucleic acid reassembly in directed evolution |
| 10/21/2003 | US6635440 Method of isolation of RNA-binding compounds |
| 10/21/2003 | US6635439 Hydrogen peroxide indicator employing enzyme and dye |
| 10/21/2003 | US6635438 Enzymatic cycling assays for homocysteine and cystathionine |
| 10/21/2003 | US6635437 Useful in methods for producing light and in assays for phosphatase enzymes and enzyme inhibitors and in assays employing enzyme-labeled specific binding pairs |
| 10/21/2003 | US6635436 Methods for the screening of non-recombinant cell lines capable of expressing a single PDE4 isoenzyme and for the screening of PDE4 inhibitors |
| 10/21/2003 | US6635435 Halo-pyrene substituted molecule which re-emits radiation; soluble and stable in water; large Stokers' shift; enzymatic hydrolysis; use in detection assays |
| 10/21/2003 | US6635433 Methods and materials for diagnosing unstable angina |
| 10/21/2003 | US6635431 Recombinant lipolysis stimulated (LSR) comprising polypeptide of given sequence; use for selecting a compound for enhancing lipoprotein uptake in cells expressing the polypeptide |
| 10/21/2003 | US6635429 Incubating a cell containing sequence linked to a DNA response element with an agent to determine its capability of transactivating the sequence; retinoic acid, thyroid, retinoid X |
| 10/21/2003 | US6635428 Oligonucleotides and methods for detecting hepatitis B viral nucleic acids |
| 10/21/2003 | US6635427 Kit for use in the amplification and quantification of preferential sequences |
| 10/21/2003 | US6635426 Detection gene expression; measurement mutant genomes; laser radiation |
| 10/21/2003 | US6635425 Synthesis of a single stranded circular DNA containing a phosphorothioate linkage at the site of ligation junction. |
| 10/21/2003 | US6635424 Method for generating libraries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules |
| 10/21/2003 | US6635423 Informative nucleic acid arrays and methods for making same |
| 10/21/2003 | US6635422 Partitioning cellular ribonuclic acid protein structures; incubate sample with ligand, form complex on solid upport, remove ribonuclic acid complex from support |
| 10/21/2003 | US6635419 Using target-specific primers which contain a binding segment and a mobility-reducing moiety; reacting with primer extension reagent; separating electrophoretically using a sieving matrix and detecting signal |
| 10/21/2003 | US6635418 Assay methods for nucleic acid in a sample |
| 10/21/2003 | US6635417 Complex formation between DSDNA and oligomer of cyclic heterocycles |
| 10/21/2003 | US6635257 Oligomeric particle having diameter of 1 to 100 nanometer and consisting of hepatitis C virus envelope proteins, or parts thereof, in which at least one cysteine is alkylated |
| 10/21/2003 | US6635255 CASB414:antigen overexpressed in several tumors |
| 10/21/2003 | CA2341231C Instrument for selecting and depositing multicellular organisms and other large objects |
| 10/21/2003 | CA2294516C Ikk-.beta. proteins, nucleic acids and methods |
| 10/21/2003 | CA2259123C Oligonucleotides from the untranslated regions of ribonucleotide reductase and their use to modulate cell growth |
| 10/16/2003 | WO2003085585A1 A method for gene mapping from genotype and phenotype data |
| 10/16/2003 | WO2003085405A1 Method for selecting bioactive agents by detecting variation induced in cyclic amp intracellular concentration of a sensitive living cell |
| 10/16/2003 | WO2003085404A1 Methods for detecting ovarian cancer |
| 10/16/2003 | WO2003085400A1 Onset of force development as a marker of thrombin generation |
| 10/16/2003 | WO2003085379A2 Microfluidic particle-analysis systems |
| 10/16/2003 | WO2003085378A2 Detection of wheat and barley fungal pathogens which are resistant to certain fungicides using the polymerase chain reaction |
| 10/16/2003 | WO2003085377A2 Novel pancortin-pablo protein interactions and methods of use thereof |